Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

As cell therapies quickly advance from pre-clinical stage into clinical and commercial applications, the design and implementation of scalable manufacturing platform technologies continues to be a focus for the field. Despite the successful commercialization of several cell therapies, bottlenecks in manufacturing throughput and capacity continue to hinder patient access to these life-saving treatments.

This webinar will explore the current landscape and limitations of cell therapy manufacturing platforms and share insights into how to choose a technology platform that assures flexibility in process development and scalability for clinical and commercial success.

• Challenges and opportunities associated with current cell therapy manufacturing platforms
• The flexibility of translating CAR T manufacturing processes to the Lonza Cocoon^® Platform
• How to ensure process flexibility that enables rapid implementation of iterative manufacturing improvements

Peter Yates

Director, Product Management - Personalized Medicine, Lonza